JBTM vs XE: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
JBTM is the larger of the two ($5.41B market cap): the incumbent the market prices for continued execution (11.30x forward earnings, beta 0.94). XE is the smaller challenger ($4.21B), priced similarly on forward earnings (-18.90x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
JBTM vs XE: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | JBTM | XE | What it tells you |
|---|---|---|---|
| Market cap | $5.41B | $4.21B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 11.30 | -18.90 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 1% of range | 1% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.20 | 1.64 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how JBTM and XE affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. JBTM and XE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined JBTM and XE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does JBT Marel Corporation (JBTM) do?
JBT Marel Corporation (formerly John Bean Technologies) is a leading technology and equipment supplier to the food and beverage industry, operating in more than 30 countries. It sells processing, preparation, preservation, packaging, and automation systems across poultry, meat, fish, pet food, prepared foods, and beverages, and generates a meaningful and growing share of revenue from recurring aftermarket parts, service, and software. The company reorganized around two reportable segments, Protein Solutions and Prepared Food and Beverage Solutions, after closing its roughly $4.4 billion acquisition of Marel hf. in early 2025 and rebranding as JBT Marel.
What does X-Energy (XE) do?
X-Energy, Inc. designs advanced small modular nuclear reactors and manufactures the fuel that powers them. Its flagship Xe-100 is a high-temperature gas-cooled reactor sized at roughly 80 megawatts of electric output (200 megawatts thermal), aimed at industrial sites and data centers, and its TRISO-X fuel business makes the coated-particle fuel the reactors run on. Founded in 2009 and headquartered in Rockville, Maryland, the company is developing its first Xe-100 plant at Dow's Seadrift site on the Texas Gulf Coast under the U.S. Department of Energy's Advanced Reactor Demonstration Program, and has offtake and partnership arrangements tied to Amazon, Dow, Centrica, Talen Energy, and utilities in Kentucky.
JBTM vs XE: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- JBTM drivers: Marel merger integration and synergies; Recurring aftermarket and software.
- XE drivers: AI and data-center power demand; Government backing and the Dow demonstration.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The business is cyclical and tied to capital-spending decisions by food processors, so orders can soften in a downturn. For XE, x-Energy is pre-commercial, so it generates large losses and has no proven history of building and operating reactors at scale.
JBTM or XE: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick JBTM if you believe its drivers more; XE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the JBTM and XE guides.
JBTM vs XE: the full fundamentals
JBTM. JBT Marel guided full-year 2026 revenue of roughly $3.99 to $4.065 billion with an adjusted EBITDA margin of about 17.0 to 17.5 percent. The trailing GAAP multiple of ~29 times is inflated by deal amortization, M&A costs and the Q2 impairment; on forward earnings the stock trades near ~11 times and about ~11 times EV to EBITDA, far below where it sat in mid-2026, which reflects the market's doubts about integration timing. The 8 analysts tracked by Yahoo Finance carry a mean target near ~$167, and Barclays started coverage in September at $150.
XE. As of October 2026, X-Energy still trades at a very high multiple of its modest revenue (about 28 times trailing sales) because the market is pricing future reactor deployments rather than current results, though that multiple has compressed as the share price fell about 65% this year. Revenue is growing quickly but losses remain large as the company invests in licensing, fuel facilities, and its first plant, and the April 2026 IPO left about $1.64 billion of cash on the balance sheet. Third-quarter results are due November 16, 2026, with consensus near $60.6 million of revenue and a loss of about $0.12 per share.
Headline figures (approximate, October 2026): JBTM shows revenue (ttm) ~$3.93B; Q2 2026 ~$981M (+5% YoY), adj. ebitda margin (q2 2026) ~17.1%; FY2026 guide 17.0% to 17.5%, net income (ttm) ~$193M, a ~4.9% net margin, adj. eps (q2 2026) ~$1.95 vs ~$2.02 expected; XE shows share price ~$10.32 (Oct 16, 2026), market cap ~$4.2B, revenue (ttm) ~$150M, revenue growth (latest quarter, yoy) ~196%.
The bottom line: JBTM vs XE
JBTM and XE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined JBTM and XE exposure against your real portfolio. It is not an investment adviser.
Wondering how JBTM or XE fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in JBT Marel Corporation with AI
Connect the broker you already use and ask Walnut's AI how JBTM fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between JBTM and XE?
+
JBT Marel Corporation (formerly John Bean Technologies) is a leading technology and equipment supplier to the food and beverage industry, operating in more than 30 countries. X-Energy, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is JBTM or XE the better stock?
+
Neither is universally better. JBTM is the larger incumbent; XE is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, JBTM or XE?
+
On forward P/E (as of October 2026), JBTM trades at 11.30x and XE at -18.90x, so XE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both JBTM and XE?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of JBTM vs XE?
+
JBTM: The business is cyclical and tied to capital-spending decisions by food processors, so orders can soften in a downturn. The Marel integration carries execution risk, and the June 2026 quarter showed it: logistics constraints and productivity inefficiencies weighed on Prepared Food and Beverage Solutions, adjusted EPS missed consensus, and a $33 million impairment on a 2021 acquisition hit GAAP results. Higher inflationary costs are being offset with pricing, which may not fully hold. Failing to realize the targeted synergies or margin expansion would pressure a stock that has already fallen about 30 percent in 2026 on doubts about exactly that. Debt taken on for the acquisition raises interest and refinancing sensitivity, and a large share of revenue is international, exposing results to foreign-exchange swings (currency added about 6 points to Q1 2026 growth and about 2 points to Q2). Short interest was reported near 9 percent of float in September, and end-market concentration in protein and reliance on continued equipment demand add further variability. XE: X-Energy is pre-commercial, so it generates large losses and has no proven history of building and operating reactors at scale. Trailing revenue near $150 million against a market cap of roughly $4.2 billion (about 28 times sales as of October 2026) means the valuation is priced for deployments that are years away and not yet certain. Nuclear projects face long regulatory timelines, potential cost overruns, and construction delays, and the Xe-100 still needs NRC licensing and first-plant completion. Much of the pipeline consists of studies, offtake agreements, and memorandums rather than firm binding orders, and the company depends on continued government support and capital markets access. A shift in policy, a project setback, or dilution from future capital raises could weigh heavily on the shares. The stock has already shown how volatile it is: it fell about 35% in the month to October 16, 2026 to a 52-week low, and Morgan Stanley cut its price target from $41 to $34 in October while keeping an Overweight rating.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell JBTM or XE; figures are approximate and dated (as of October 2026). Verify current data before investing.